期刊文献+

深圳市泌尿生殖道解脲支原体和人型支原体感染状况及药物敏感性分析 被引量:2

Detection and evaluation of antibiotic susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Shenzhen area
下载PDF
导出
摘要 目的 了解深圳市泌尿生殖道支原体感染状况及耐药性变化趋势 ,指导临床合理用药。方法 用My coplasmaIST试剂盒对深圳市 2 0 0 2年 84 6 0例泌尿生殖道感染患者 ,取尿道 (宫颈 )分泌物进行了解脲支原体 (Uu)和人型支原体 (Mh)的培养鉴定及药敏检测。结果 Uu单独感染 2 0 6 7例 ,Mh单独感染 5 4例 ,Uu和Mh混合感染 6 78例。男性感染率为 2 7 2 % ,女性感染率为 4 0 2 %。药敏试验显示 :Uu对氧氟沙星的敏感性下降至 36 1% ,Mh对红霉素和四环素的敏感性分别降至 9 3%和 4 8 1% ,原始霉素、交沙霉素对两种支原体都保持稳定的高敏感性。结论 支原体的混合感染、耐药性上升趋势十分严重 ,交沙霉素应作为目前治疗泌尿生殖道Uu和Mh感染的首选 ,支原体耐药性的长期监测是指导临床治疗的重要依据。 Objective To investigate the infections in urogenital tract and changing trend of drug susceptibility of mycoplasma in Shenzhen area. Methods U.ruealyticum(Uu)and M. hominis(Mh)were detected in 8,460 cases with urogenital tract infection,and the susceptibility of clinical strains to antibiotics were determined using Mycoplasma IST kit. Results 2,067 of cases were infected by U.urealyticum,54 cases were infected by M.hominis and 678 cases were positive with both species. 27.2% male were positive and 40.2% of female were positive.Only 36.1% of U u strains were susceptive to ofloxacin. 9.3% and 48.1% of Mh strains were susceptive to erythromycin and tetracycline,respectively. Pristinamycin and josamycin were the most active agents against both species. Conclusion Mixed infection and increasing resistance of mycoplasmas is a serious problem. Multiple resistance to two or more antibiotics were frequent. In view of the susceptibility of M.hominis and U.urealyticum strains to josamycin,it was still the first candidate drug against Uu and Mh. This finding also indicated that resistance monitoring of mycoplasma periodically has important significance in clinical practices.
出处 《中国艾滋病性病》 CAS 2004年第4期284-285,300,共3页 Chinese Journal of Aids & STD
  • 相关文献

参考文献5

二级参考文献8

共引文献36

同被引文献13

  • 1任南,文细毛,吴安华.165所医院住院患者抗菌药物临床应用横断面调查[J].中国医师杂志,2007,9(5):633-635. 被引量:38
  • 2Cohen MS,Anderson DJ.Genitourinary mucosal defenses.Holmes KK,Kardh PA,Sparling PF,et al.eds.Sexual Transmitted Diseases.3rd ed.New York:MCGraw-Hill,1999.173-190.
  • 3Karabay O,Topcuogiu A,Kocoglu E,et al.Prevalence and antibiotic susceptibility of genital Mycoplasma hominis and Ureaplasma urealyticum in a university hospital in Turkey.Clin Exp Obstet Gynecol 2006;33(1):36-38.
  • 4Bradshaw CS,Jensen JS,Tabrizi,et al.Azithromycin failure in Mycoplasma genitalium urethritis.Emerg Infect Dis 2006;12(7):1149-1152.
  • 5Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR - 936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin - dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyelines, and quinolones[J]. Antimicrob Agents Chemother. 2001,45(9) :2604 - 2608.
  • 6Center for Disease Control and Prevention (2002) : Disease characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines [J]. Morbid. Mortal. Wkly. Rep., 51(RR-6):30-42.
  • 7Ullmann U, Schubert S, Krausse R. Comparative in - vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis [ J ]. J Antimicrob Chemother. 1999 ,43 Suppl C :33 - 36.
  • 8Kilic D, Basar MM, Kaygusuz S, et al. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non- gonoceccal urethritis[J]. Jpn J Infect Dis. 2004,57 (1):17-20.
  • 9Karabay O, Topcuoglu A, Kocoglu E, et al. Prevalence and antibiotic susceptibility of genital Mycoplasma hominis and Ureaplasma urealyticum in a university hospital in Turkey[J]. Clin Exp Obstet Gynecol, 2006, 33 (1):36 - 38.
  • 10Fumed, P. M., G. Rappazzo, M. P. Musumarra, et al. Genetic basis of natural resistance to erythremycin by Mycoplasma bominis[J]. J. Antimicrob. Chemother, 2000, 45(4): 547 - 548.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部